These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31771862)

  • 21. Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives.
    Guillaume D; Waheed DE; Schlieff M; Muralidharan K; Vorsters A; Limaye R
    Hum Vaccin Immunother; 2022 Dec; 18(7):2150454. PubMed ID: 36485172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of human papillomavirus immunization in the developing world.
    Kane MA; Serrano B; de Sanjosé S; Wittet S
    Vaccine; 2012 Nov; 30 Suppl 5():F192-200. PubMed ID: 23199963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Status of HPV vaccine introduction and barriers to country uptake.
    Gallagher KE; LaMontagne DS; Watson-Jones D
    Vaccine; 2018 Aug; 36(32 Pt A):4761-4767. PubMed ID: 29580641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.
    Obel J; McKenzie J; Buenconsejo-Lum LE; Durand AM; Ekeroma A; Souares Y; Hoy D; Baravilala W; Garland SM; Kjaer SK; Roth A
    Asian Pac J Cancer Prev; 2015; 16(8):3435-42. PubMed ID: 25921158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: A comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda.
    Howard N; Walls H; Bell S; Mounier-Jack S
    Vaccine; 2018 Sep; 36(37):5536-5543. PubMed ID: 30076103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in the establishment and strengthening of national immunization technical advisory groups: analysis from the 2013 WHO/UNICEF joint reporting form, data for 2012.
    Duclos P; Dumolard L; Abeysinghe N; Adjagba A; Janusz CB; Mihigo R; Mosina L; Takashima Y; Oztürk MH
    Vaccine; 2013 Nov; 31(46):5314-20. PubMed ID: 24055304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current issues facing the introduction of human papillomavirus vaccine in China and future prospects.
    Wong LP; Han L; Li H; Zhao J; Zhao Q; Zimet GD
    Hum Vaccin Immunother; 2019; 15(7-8):1533-1540. PubMed ID: 31017500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National immunization technical advisory groups (NITAGs) in the WHO Eastern Mediterranean Region (EMR): A decade of shaping immunization policies, 2010-2021.
    Etapelong Sume G; Quamrul H; Md S; Kissa J; Hutin Y
    Vaccine; 2024 Jan; 42(3):629-635. PubMed ID: 38143199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus vaccine disease impact beyond expectations.
    de Sanjose S; Brotons M; LaMontagne DS; Bruni L
    Curr Opin Virol; 2019 Dec; 39():16-22. PubMed ID: 31382121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Social and cultural construction processes involved in HPV vaccine hesitancy among Chinese women: a qualitative study.
    Siu JY; Fung TKF; Leung LH
    Int J Equity Health; 2019 Sep; 18(1):147. PubMed ID: 31533722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program.
    Paul P; Fabio A
    Vaccine; 2014 Jan; 32(3):320-6. PubMed ID: 24295804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supporting National Immunization Technical Advisory Groups (NITAGs) in development of evidence-based vaccine recommendations and NITAG assessments - New tools and approaches.
    Hadler SC; Shefer AM; Cavallaro KF; Ebama M; Tencza C; Kennedy ED; Ndiaye S; Shah A; Torre L; Bresee JS
    Vaccine; 2024 Oct; 42 Suppl 4(Suppl 4):125610. PubMed ID: 38267328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(40):1382-4. PubMed ID: 21993342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HPV vaccine uptake in men who have sex with men in Scotland.
    Pollock KG; Wallace LA; Wrigglesworth S; McMaster D; Steedman N
    Vaccine; 2019 Sep; 37(37):5513-5514. PubMed ID: 30545714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Views of parents regarding human papillomavirus vaccination: A systematic review and meta-ethnographic synthesis of qualitative literature.
    Marshall S; Fleming A; Moore AC; Sahm LJ
    Res Social Adm Pharm; 2019 Apr; 15(4):331-337. PubMed ID: 29804879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide.
    Owsianka B; Gańczak M
    Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value and effectiveness of National Immunization Technical Advisory Groups in low- and middle-income countries: a qualitative study of global and national perspectives.
    Bell S; Blanchard L; Walls H; Mounier-Jack S; Howard N
    Health Policy Plan; 2019 May; 34(4):271-281. PubMed ID: 31074778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.